![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
GW Pharm. | LSE:GWP | London | Ordinary Share | GB0030544687 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 735.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMGWP
RNS Number : 4529B
GW Pharmaceuticals PLC
17 February 2011
BLOCKLISTING INTERIM REVIEW
1. NAME OF COMPANY:
GW PHARMACEUTICALS PLC
2. NAME OF SCHEME:
GW PHARMACEUTICALS APPROVED COMPANY SHARE OPTION SCHEME
3. PERIOD OF RETURN:
FROM: 1 NOVEMBER 2009 TO: 17 FEBRUARY 2011
4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD:
145,400 ORDINARY SHARES OF 0.1P EACH
5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD:
67,500 ORDINARY SHARES OF 0.1P EACH
6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD:
77,900 ORDINARY SHARES OF 0.1P EACH
7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY LISTED AND THE DATE OF ADMISSION:
507,146 ORDINARY SHARES OF 0.1P EACH ON 7 OCTOBER 2003
PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS.
131,549,592 ORDINARY SHARES OF 0.1P EACH
BLOCKLISTING INTERIM REVIEW
1. NAME OF COMPANY:
GW PHARMACEUTICALS PLC
2. NAME OF SCHEME:
GW PHARMACEUTICALS APPROVED SHARE OPTION SCHEME 2001
3. PERIOD OF RETURN:
FROM: 01 NOVEMBER 2009 TO: 17 FEBRUARY 2011
4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD:
384,958 ORDINARY SHARES OF 0.1P EACH
5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD:
102,000 ORDINARY SHARES OF 0.1P EACH
6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD:
282,958 ORDINARY SHARES OF 0.1P EACH
7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY LISTED AND THE DATE OF ADMISSION:
516,558 ORDINARY SHARES OF 0.1P EACH ON 21 JULY 2004
PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS.
131,549,592 ORDINARY SHARES OF 0.1P EACH
BLOCKLISTING INTERIM REVIEW
1. NAME OF COMPANY:
GW PHARMACEUTICALS PLC
2. NAME OF SCHEME:
GW PHARMACEUTICALS UNAPPROVED SHARE OPTION SCHEME 2001
3. PERIOD OF RETURN:
FROM: 01 NOVEMBER 2009 TO: 17 FEBRUARY 2011
4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD:
1,276,492 ORDINARY SHARES OF 0.1P EACH
5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD:
657,833 ORDINARY SHARES OF 0.1P EACH
6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD:
618,659 ORDINARY SHARES OF 0.1P EACH
7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY LISTED AND THE DATE OF ADMISSION:
1,279,192 ORDINARY SHARES OF 0.1P EACH ON 21 JULY 2004
PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS.
131,549,592 ORDINARY SHARES OF 0.1P EACH
BLOCKLISTING INTERIM REVIEW
1. NAME OF COMPANY:
GW PHARMACEUTICALS PLC
2. NAME OF SCHEME:
GW PHARMACEUTICALS EXECUTIVE SHARE OPTION SCHEME
3. PERIOD OF RETURN:
FROM: 1 NOVEMBER 2009 TO: 17 FEBRUARY 2011
4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD:
212,612 ORDINARY SHARES OF 0.1P EACH
5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD:
212,612 ORDINARY SHARES OF 0.1P EACH
6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD:
NIL ORDINARY SHARES OF 0.1P EACH.
7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY LISTED AND THE DATE OF ADMISSION:
1,388,375 ORDINARY SHARES OF 0.1P EACH ON 7 OCTOBER 2003
300,000 ORDINARY SHARES OF 0.1P EACH ON 23 APRIL 2008
400,000 ORDINARY SHARES OF 0.1P EACH ON 18 JANUARY 2010
PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS.
131,549,592 ORDINARY SHARES OF 0.1P EACH
For further information, please contact:
Adam George, Company Secretary, GW Pharmaceuticals plc
Telephone: +44 (0)1980 557000
James Steel/Vijay Barathan, Nominated Adviser, Peel Hunt LLP
Telephone: +44 (0)20 7418 8900
This information is provided by RNS
The company news service from the London Stock Exchange
END
BLRDDLFFFLFZBBL
1 Year Gw Pharmaceuticals Chart |
1 Month Gw Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions